Is Basilea Pharmaceutica AG stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Basilea Pharmaceutica AG pays dividends. Last time was Friday 21st of June 2013 where the investors holding the stock on Thursday 11th of April 2013 were paid CHF5 per share. Over the last 1 times between 2013 and 2013, Basilea Pharmaceutica AG has paid CHF5 with an average of CHF5 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Basilea Pharmaceutica AG 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CHF45.50, you would have made a loss of CHF-0.250 per share or -0.55%
Yes, the average daily trading liquidity for Basilea Pharmaceutica AG is CHF26 606 thousand. You should therefore be able to get in and out of your positions relatively fast.
Basilea Pharmaceutica AG has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.13, the company's ability to pay off the debt is normal. Basilea Pharmaceutica AG has a good net profit margin of 6.63% and should have high tolerances against inflation.
We have calculated the inflation risk for Basilea Pharmaceutica AG to be medium [0.55 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.